文献速递产科母胎医学

美国大型出生队列中COVID-19疫情期间的不良围产结局

Adverse perinatal outcomes in a large United States birth cohort during the COVID-19 pandemic.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-02-01

该观察性队列研究纳入2019年1月1日至2021年5月31日住院分娩或流产的683905例12至50岁患者,比较COVID-19与非COVID-19孕产妇的院内不良围产结局,并比较疫情期间与疫情前的不良结局发生率。结果显示,COVID-19孕产妇的早产、子痫前期、弥散性血管内凝血、肺水肿及机械通气风险升高,院内死亡率更高;诊断距住院≤30天者风险最高;疫情期间与疫情前的不良结局无差异。

要点

  • COVID-19孕产妇的早期和晚期早产风险升高,调整比值比分别为1.38和1.62。
  • COVID-19孕产妇的机械通气风险显著升高,调整比值比为8.1,院内死亡率也更高。
  • 诊断COVID-19距住院≤30天者发生早期早产、胎盘早剥和机械通气的风险高于诊断距住院>30天者。

核心结论

  • COVID-19孕产妇的不良围产结局发生率和院内死亡率更高,诊断距住院≤30天时风险最高,提示可能存在高风险期。

研究设计与样本

  • 观察性队列研究,纳入2019年1月1日至2021年5月31日住院分娩或流产的683905例12至50岁患者。
  • 疫情前住院分娩271444例;疫情期间住院分娩308532例,其中2708例患COVID-19。
  • 采用倾向评分校正的逻辑回归分析COVID-19与院内不良围产结局的关联。

主要发现

  • COVID-19孕产妇的早期早产调整比值比为1.38(95%CI 1.1-1.7),晚期早产为1.62(95%CI 1.3-1.7)。
  • COVID-19孕产妇的子痫前期调整比值比为1.2(95%CI 1.0-1.4),弥散性血管内凝血为1.57(95%CI 1.1-2.2),肺水肿为2.7(95%CI 1.1-6.3),机械通气为8.1(95%CI 3.8-17.3)。
  • COVID-19孕产妇与无COVID-19孕产妇的死胎发生率无显著差异(16/2708 vs 174/39562,P=.257)。
  • 疫情期间分娩与疫情前分娩的孕产妇不良结局无差异。
  • COVID-19孕产妇的合并院内死亡率显著更高(每10万孕产妇147例死亡[95%CI 3.0-292.0] vs 2.5例[95%CI 0.0-7.5])。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of coronavirus disease 2019 (COVID-19) on adverse perinatal outcomes remains unclear. OBJECTIVE: This study aimed to investigate whether COVID-19 is associated with adverse perinatal outcomes in a large national dataset and to examine the rates of adverse outcomes during the pandemic compared with the rates of adverse outcomes during the prepandemic period. STUDY DESIGN: This observational cohort study included 683,905 patients, between the ages of 12 and 50, hospitalized for childbirth and abortion between January 1, 2019, and May 31, 2021. During the prepandemic period, 271,444 women were hospitalized for childbirth. During the pandemic, 308,532 women were hospitalized for childbirth, and 2708 women had COVID-19. The associations between COVID-19 and inhospital adverse perinatal outcomes were examined using propensity score-adjusted logistic regression. RESULTS: Women with COVID-19 were more likely to experience both early and late preterm birth (adjusted odds ratios, 1.38 [95% confidence interval, 1.1-1.7] and 1.62 [95% confidence interval, 1.3-1.7], respectively), preeclampsia (adjusted odds ratio, 1.2 [95% confidence interval, 1.0-1.4]), disseminated intravascular coagulopathy (adjusted odds ratio, 1.57 [95% confidence interval, 1.1-2.2]), pulmonary edema (adjusted odds ratio, 2.7 [95% confidence interval, 1.1-6.3]), and need for mechanical ventilation (adjusted odds ratio, 8.1 [95% confidence interval, 3.8-17.3]) than women without COVID-19. There was no significant difference in the prevalence of stillbirth among women with COVID-19 (16/2708) and women without COVID-19 (174/39,562) (P=.257). There was no difference in adverse outcomes among women who delivered during the pandemic vs prepandemic period. Combined inhospital mortality was significantly higher for women with COVID-19 (147 [95% confidence interval, 3.0-292.0] vs 2.5 [95% confidence interval, 0.0-7.5] deaths per 100,000 women). Women diagnosed with COVID-19 within 30 days before hospitalization were more likely to experience early preterm birth, placental abruption, and mechanical ventilation than women diagnosed with COVID-19 >30 days before hospitalization for childbirth (4.0% vs 2.4% for early preterm birth [adjusted odds ratio, 1.7; 95% confidence interval, 1.1-2.7]; 2.2% vs 1.2% for placental abruption [adjusted odds ratio, 1.86; 95% confidence interval, 1.0-3.4]; and 0.9% vs 0.1% for mechanical ventilation [adjusted odds ratio, 13.7; 95% confidence interval, 1.8-107.2]). CONCLUSION: Women with COVID-19 had a higher prevalence of adverse perinatal outcomes and increased in-hospital mortality, with the highest risk occurring when the diagnosis was within 30 days of hospitalization, raising the possibility of a high-risk period.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Litman EA, Yin Y, Nelson SJ, et al. Adverse perinatal outcomes in a large United States birth cohort during the COVID-19 pandemic. Am J Obstet Gynecol MFM. 2022. PMID: 35114422. doi:10.1016/j.ajogmf.2022.100577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。